Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;40(3):283-299.
doi: 10.1007/s10571-019-00733-0. Epub 2019 Sep 9.

The Impact of Estradiol on Neurogenesis and Cognitive Functions in Alzheimer's Disease

Affiliations
Review

The Impact of Estradiol on Neurogenesis and Cognitive Functions in Alzheimer's Disease

Sajad Sahab-Negah et al. Cell Mol Neurobiol. 2020 Apr.

Abstract

Alzheimer's disease (AD) is described as cognitive and memory impairments with a sex-related epidemiological profile, affecting two times more women than men. There is emerging evidence that alternations in the hippocampal neurogenesis occur at the early stage of AD. Therapies that may effectively slow, stop, or regenerate the dying neurons in AD are being extensively investigated in the last few decades, but none has yet been found to be effective. The regulation of endogenous neurogenesis is one of the main therapeutic targets for AD. Mounting evidence indicates that the neurosteroid estradiol (17β-estradiol) plays a supporting role in neurogenesis, neuronal activity, and synaptic plasticity of AD. This effect may provide preventive and/or therapeutic approaches for AD. In this article, we discuss the molecular mechanism of potential estradiol modulatory action on endogenous neurogenesis, synaptic plasticity, and cognitive function in AD.

Keywords: Brain; Cell therapy; Dementia; Hormone; Neurodegeneration; Neurogenesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurobiol Aging. 2003 Nov;24(7):977-83 - PubMed
    1. Mol Neurobiol. 2017 Dec;54(10):7656-7669 - PubMed
    1. Exp Neurol. 2019 Jan;311:33-43 - PubMed
    1. J Alzheimers Dis. 2018;64(s1):S497-S505 - PubMed
    1. Front Pharmacol. 2013 Mar 01;4:16 - PubMed

LinkOut - more resources